HopeStage
Back to all studies
TerminatedNCT00725270

Treatment of Schizoaffective Disorder Using Mifepristone

Medication studyAges 18–75United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 75 years.

Listed locations
StanfordSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateApril 1998
Recruitment status
Terminated
Enrollment listed in the registry
12
Sponsor
Stanford University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT00725270
Official title
Show the full official title

Treatment of Schizoaffective Disorder Using Mifepristone

Recruitment & locations

Terminated

Stanford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stanford University, a university.

Does this study involve medication?

Yes. The study involves medication, including Mifepristone and Placebo Oral Tablet.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies